Consensus Extendicare Inc.

Equities

EXE

CA30224T8639

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.3 ^CAD	0.00%		+0.55%	+0.27%

Mar. 11	Extendicare Price Target Raised to $8 at RBC	MT
Mar. 08	Transcript : Extendicare Inc., Q4 2023 Earnings Call, Mar 08, 2024

Evolution of the average Target Price on Extendicare Inc.

Price target over the last 5 years

History of analyst recommendation changes

11e61b572ab1dfafb1b0aff.duuF2L4eyEMDEkR3-KPHITOqqClIyQmSZzj0Qv97emU.AaH3nYp5sBxOZgs2rs2pY1uY2GULhUbGIEHEFpIdHxQeiMCy1yaSekJ8AQ~ed5e41248760dc09ea55e55fce617bdb

Analyst Recommendations on Extendicare Inc.

Extendicare Price Target Raised to $8 at RBC	Mar. 11	MT
National Bank Reiterates Rating on Extendicare After Reporting Q1 Results Above Forecast; Raises Price Target	23-05-09	MT
National Bank Reiterates Sector Perform Rating on Extendicare	22-08-22	MT
Extendicare Inc. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Tax Rate on FFO Guidance for the Year 2018	18-08-09	CI
Extendicare Inc. Reports Un-Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Provides Effective Tax Rate Guidance for the Year 2018	18-05-10	CI

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

7.3 CAD

Average target price

8 CAD

Spread / Average Target

+9.59%

High Price Target

8.5 CAD

Spread / Highest target

+16.44%

Low Price Target

7.5 CAD

Spread / Lowest Target

+2.74%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Extendicare Inc.

RBC Capital Markets

Quarterly revenue - Rate of surprise

Company calendar